Physician profile
Christopher M Nichols
NPI 1659477610
$79,538.32
in general payments reported to CMS, 2019-2025
18 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $29K · 2021: $17K · 2022: $20K · 2023: $2,953 · 2024: $8,359 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $2,010 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,185.16 |
| Food and Beverage | $2,010.25 |
| Travel and Lodging | $544.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $72,400.17 | 2020-2025 | |
| Fujifilm Sonosite, INC. | $5,174.13 | 2024 | |
| Stryker Corporation | $745.08 | 2019 | |
| Sientra, INC. | $419.27 | 2019-2022 | |
| Becton, Dickinson and Company | $130.40 | 2025 | Galaflex |
| Abbvie INC. | $119.95 | 2023-2025 | |
| Motiva USA, LLC | $95.43 | 2024-2025 | |
| Ge Healthcare | $94.94 | 2023 | |
| Medline Industries LP | $78.28 | 2019 | |
| Allergan, INC. | $56.19 | 2019-2022 | |
| Merz North America, INC. | $44.11 | 2019-2020 | |
| Revance Therapeutics, INC. | $39.67 | 2025 | Daxxify |
| Smith+Nephew, INC. | $36.45 | 2021-2024 | Stravix |
| Mentor Worldwide LLC | $30.51 | 2019-2025 | Mentor Siltex Round Spectrum |
| Integra Lifesciences Corporation | $30.44 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $17.76 | 2019 | |
| Tei Biosciences INC | $13.25 | 2019 | |
| Galderma Laboratories, L.P. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.